Buradasınız

Anasayfa » Content

Hemodiyaliz Hastalarında L-Karnitin Tedavisi

L-Carnitine Therapy on Hemodialysis Patients

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2005

Key Words:

Keywords (Original Language):

Author Name
Abstract (2. Language): 
The role of carnitine as a transport molecule to facilitate fatty acid metabolism and energy production has been studied extensively. Adequate carnitine levels are critical to normal function in tissues of the heart and skeletal muscle. Carnitine is a water-soluble low-molecular-weight molecule that is effectively removed from plasma by dialysis. Approximately 75% of free carnitine is removed from plasma during each dialysis session. The clinical topics presented in this supplement were selected on the basis of available evidence for a possible beneficial effect of L-carnitine replacement therapy on skeletal muscle, cardiac musc¬le, and red blood cell function.
Bookmark/Search this post with
Abstract (Original Language): 
Yağ asidi metabolizmasında ve enerji üretiminde rol alan kar-nitin üzerinde yoğun çalışmalar yapılmaktadır. Kalp ve kas dokularının normal fonksiyonu için belirli düzeylerde karnitin varlığı kritik önem taşımaktadır. Suda eriyen ve düşük molekül ağırlıklı olan karnitin diyaliz sırasında plazmadan uzaklaştırılmaktadır. Her diyaliz seansında plazmadaki serbest karnitinin yaklaşık %75'i kaybedilmektedir. Hemodiyaliz uygulanan hastalarda karnitin eksikliği gelişebilir ve karnitin tedavisi hastaların fonksiyonel kapasitesini önemli ölçüde iyileştirmektedir. Klinikte karnitin replasman tedavisinin diğer muhtemel olumlu etkileri iskelet adalesi, kalp ve eritrosit fonksiyonu üzerinedir.
FULL TEXT (PDF): 
PDF icon pdf_tndt_521.pdf
  • 2
62-64
  • Turkish

REFERENCES

References: 

1. Mitchell ME. Carnitine metabolism in human subject. Am J Clin Nutr 1978;31:293-306.
2. Bremer J. Carnitine-Metabolism and functions. Physiol Rev
1983;63:1420-1480.
3. Rebouche CJ, Paulson DJ. Carnitine metabolism and function in humans. Ann Rev Nutr 1986;6:41-66.
4. Siliprandi N, DiLisa F, Menabo R, et al. Transport and functi¬ons of carnitine in muscles. J Clin Chem Clin Biochem 1990; 28(5):246-254.
5. Bremer J. The role of carnitine in intracellular metabolism. J
Clin Chem Clin Biochem 1990;28(5):297-301.
6. Ramsay RR. The role of the carnitine system in peroxismal
fatty acid oxidation. Am J Med Sci 1999;318:28-35.
7. Hoppel C. The role of carnitine in normal and altered fatty acid metabolism. Am J Kidney Dis 2003;41(suppl 4):S4-S12.
8. Evans A. Dialysis-related carnitine disorder and levocarnitine pharmacology. Am J Kidney Dis 2003;41(suppl 4):S13-S26.
9. Leschke M, Rumpf KW, Eisenhauer T, et al. Quantitative as¬sessment of carnitine loss during hemodialysis and hemofilt-ration. Kidney Int 1983;(suppl 16):S143-S146.
10. Kletzmayr J, Mayer G, Legenstein E, et al. Anemia and carni-tine supplementation in hemodialyzed patients. Kidney Int 1999;(suppl 69):S93-S106.
11. Caruso U, Leone L, Cravotto E, Nava D. Effects of L-carnitine on anemia in aged hemodialysis patients with recombinant human erythropoietin: A pilot study. Dial Transplant 1998; 27:499-506.
12. Golper TA, Goral S, Becker BN, Langman CB. L-carnitine treat¬ment of anemia. Am J Kidney Dis 2003;41(suppl 4):S27-S34.
13. Kawabata M, Kasuga S, Hara H, et al. Erythropoietin-resistant refractory renal anemia: Effects of oral L-carnitine supple¬mentation. Clin Nephrol 2001;55:265-266.
14. Nikolaos S, George A, Telemachos T, et al. Effect of L-carni-tine supplementation on red blood cell deformability in he-modialysis patients. Ren Fail 2000;22:73-80.
15. Pauly DF, Pepine CJ. The role of carnitine in myocardial dysfunction. Am J Kidney Dis 2003;41(suppl 4):S35-S43.
16. Iyer R, Gupta A, Khan A, et al. Does left ventricular function improve with L-carnitine after acute myocardial infarction ? J
Posgrad Med 1999;45:38-41.
17.
Şe
n S, Sarıkaya A, Gümüştaş K. Kısa ve uzun süreli L-Karni-tin tedavisinin diyaliz hastalarındaki kas metabolizmasına etkileri. T Nefrol Diyal Transplant Dergisi 1999;8(4):10-15.
18. Miller B, Ahmad S. A review of the impact of L-carnitine the¬rapy on patient functionality in maintenance hemodialysis. Am J Kidney Dis 2003;41(suppl 4):S44-S48.

Thank you for copying data from http://www.arastirmax.com